Determination of the prevalence of infection with Mycobacterium tuberculosis among persons vaccinated against Bacillus Calmette-Guerin in South Korea

被引:31
|
作者
Neuenschwander, BE
Zwahlen, M
Kim, SJ
Lee, EG
Rieder, HL
机构
[1] Fed Off Publ Hlth, Bern, Switzerland
[2] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland
[3] Korean Inst TB, Seoul, South Korea
[4] Int Union TB & Lung Dis, Paris, France
关键词
Bayes theorem; BCG vaccine; mixture model; Mycobacterium bovis; prevalence; tuberculin test; tuberculosis;
D O I
10.1093/aje/155.7.654
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The prevalence of tuberculous infection was estimated among 12,032 persons with a Bacillus Calmette-Guerin (BCG) vaccination scar and 7,788 persons without such a scar who participated in a nationwide tuberculin skin test survey conducted in the Republic of Korea in 1975. The analysis was built upon mixture models that captured the heterogeneity of indurations arising from tuberculous infection, cross-reactions due to infection with environmental mycobacteria, and BCG vaccination. The three distributions were allowed to vary by age, sex, and BCG vaccination status in the Bayesian manner, according to the prior opinion of the authors. Estimated prevalences of tuberculous infection were similar among persons with a BCG scar and persons without one: 7.5% (95% credibility interval (CI): 3.1, 12.5) and 5.2% (95% CI: 4.2, 6.3), respectively, at age 0-4 years and 87.3% (95% CI: 84.0, 90.2) and 84.0% (95% CI: 81.9, 85.8), respectively, at age 25-29 years. From this analysis it can be concluded that mixture models allow investigators, for the first time, to estimate the prevalence of tuberculous infection not only in unvaccinated persons but also in the BCG-vaccinated population. Mixture models are a versatile tool for analyzing diagnostic test data and more general classification problems of considerable complexity.
引用
收藏
页码:654 / 663
页数:10
相关论文
共 50 条
  • [31] A Novel Monoclonal Antibody Against A60 Antigen of Mycobacterium bovis Bacillus Calmette-Guerin
    Bakhtiyari, Salar
    Haghani, Karimeh
    Farhadi, Elham
    Soukhtanloo, Mohammad
    Rezaei, Nima
    Taghikhani, Mohammad
    HYBRIDOMA, 2010, 29 (03): : 211 - 215
  • [32] Characterization of lung γδ T cells following intranasal infection with Mycobacterium bovis bacillus Calmette-Guerin
    Dieli, F
    Ivanyi, J
    Marsh, P
    Williams, A
    Naylor, I
    Sireci, G
    Caccamo, N
    Di Sano, C
    Salerno, A
    JOURNAL OF IMMUNOLOGY, 2003, 170 (01): : 463 - 469
  • [33] DNA vaccination boosts Bacillus Calmette-Guerin protection against mycobacterial infection in zebrafish
    Oksanen, Kaisa E.
    Myllymaki, Henna
    Ahava, Maarit J.
    Makinen, Leena
    Parikka, Mataleena
    Ramet, Mika
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2016, 54 (01): : 89 - 96
  • [34] Bacillus Calmette-Guerin immunotherapy enhances cellular immunity against human papillomavirus infection
    Vetskova, E.
    Aleksandrova, M.
    Avramov, T.
    Nikolova, M.
    ALLERGY, 2017, 72 : 513 - 513
  • [35] Vaccination with Intradermal Bacillus Calmette-Guerin Provides Robust Protection against Extrapulmonary Tuberculosis but Not Pulmonary Infection in Cynomolgus Macaques
    Tsujimura, Yusuke
    Shiogama, Yumiko
    Soma, Shogo
    Okamura, Tomotaka
    Takano, Junichiro
    Urano, Emiko
    Murakata, Yoshiko
    Kawano, Akira
    Yamakawa, Natsuko
    Asaka, Masamitsu N.
    Matsuo, Kazuhiro
    Yasutomi, Yasuhiro
    JOURNAL OF IMMUNOLOGY, 2020, 205 (11): : 3023 - +
  • [36] Adverse reactions to Mycobacterium bovis bacille Calmette-Guerin vaccination against tuberculosis in Iranian children
    Mahmoudi, Shima
    Khaheshi, Saeid
    Pourakbari, Babak
    Aghamohammadi, Asghar
    Valian, Sepideh Keshavarz
    Bahador, Abbas
    Sabouni, Farah
    Ramezani, Amitis
    Mamishi, Setareh
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2015, 4 (02) : 195 - 199
  • [37] Comparison of the protective efficacy of bacille Calmette-Guerin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis
    Williams, A
    Davies, A
    Marsh, PD
    Chambers, MA
    Hewinson, RG
    CLINICAL INFECTIOUS DISEASES, 2000, 30 : S299 - S301
  • [38] Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guerin
    Copland, Alastair
    Diogo, Gil R.
    Hart, Peter
    Harris, Shane
    Tran, Andy C.
    Paul, Mathew J.
    Singh, Mahavir
    Cutting, Simon M.
    Reljic, Rajko
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [39] Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection
    Pi, Jiang
    Zhang, Zhiyi
    Yang, Enzhuo
    Chen, Lingming
    Zeng, Lingchan
    Chen, Yiwei
    Wang, Richard
    Huang, Dan
    Fan, Shuhao
    Lin, Wensen
    Shen, Hongbo
    Xu, Jun-Fa
    Zeng, Gucheng
    Shen, Ling
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [40] HOST-PARASITE RELATIONSHIPS IN EXPERIMENTAL AIRBORNE TUBERCULOSIS .5. LACK OF HEMATOGENOUS DISSEMINATION OF MYCOBACTERIUM-TUBERCULOSIS TO LUNGS IN ANIMALS VACCINATED WITH BACILLUS CALMETTE-GUERIN
    FOK, JS
    HO, RS
    ARORA, PK
    HARDING, GE
    SMITH, DW
    JOURNAL OF INFECTIOUS DISEASES, 1976, 133 (02): : 137 - 144